期刊文献+

分泌型磷脂酶A_2对预测急性心肌梗死行经皮冠状动脉介入治疗预后的价值 被引量:7

Prognostic Value of Plasma Type II Secretory Phospholipase A_2 Levels in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探讨血浆分泌型磷脂酶A2(sPLA2)水平对行急诊经皮冠状动脉介入(PCI)治疗的急性心肌梗死(AMI)患者长期预后的预测价值。方法:将223例行急诊PCI的AMI患者按2年随访期结束是否发生主要不良心脏事件(MACE)分为MACE组(95例)和无MACE组(128例),比较2组患者一般临床资料、血浆sPLA2水平及冠状动脉造影资料的差异。将单因素分析有意义的变量纳入Cox比例风险回归模型对预后进行多因素分析,并以无MACE组血浆sPLA2水平的P75为截断点(5.48μg/L)分为高sPLA2组和低sPLA2组,应用乘积极限法分析sPLA2预测预后的价值。结果:MACE组的男性、2型糖尿病、白细胞计数(WBC)、尿素氮(BUN)、入院血糖(Glu)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、sPLA2、多支病变(≥2支冠状动脉病变)、从发病到球囊扩张的时间和无复流的患者比例明显多于无MACE组,左室射血分数(LVEF)明显低于无MACE组;Cox回归分析显示sPLA2>5.48μg/L(RR:3.23,95%CI:1.24~12.36,P<0.001)、2型糖尿病(RR:2.78,95%CI:1.52~7.24,P<0.001)、多支病变(RR:2.37,95%CI:1.66~6.79,P<0.001)和LVEF<0.50(RR:1.74,95%CI:1.07~2.94,P=0.037)是AMI患者急诊PCI术后长期预后不良的预测因子。结论:血浆sPLA2水平的升高与行急诊PCIAMI患者的不良预后相关。 Objoctive: To evaluate the prognostic value of plasma type lI secretory phospholipase A2 (sPLA2) levels in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI). Methods: A total of 223 patients with AMI who underwent primary PCI were divided into major adverse cardiac events (MACE) group (n=95) and no-MACE group (n=128) after 2-year follow-up. The baseline characteristics, plasma level of sPLA2 and angiographie characteristics were compared between two groups. Cox's proportional hazard regression analysis was used to assess the predictive value for MACE during the follow-up period and the Kaplan-Meier method was applied in survival analysis according to the levels of sPLA2. FIosults: The proportion of male, type 2 diabetes mellitus, number of white blood cells, urea nitrogen (BUN), glucose, creatine kinase (CK), CK-MB, sPLA2, multiple (~double-vessel CAD) coronary with stenosis, symptom-to-balloon time and no-reflow after PCI were significantly higher in MACE group than those of no- MACE group. The left ventricular ejection fraction (LVEF) was lower in MACE group than that of no-MACE group. Multivariate forward stepwise Cox proportional hazard regression analysis showed that sPLA2 〉5.48 μg/L (RR: 3.23, 95%CI: 1.24-12.36, P 〈 0.001), diabetes mellitus (RR: 2.78, 95%CI: 1.52-7.24, P 〈 0.001), multiple coronary stenosis (RR: 2.37, 95%CI: 1.66-6.79, P 〈 0.001) and LVEF〈 0.50 (RR: 1.74, 95%CI: 1.07-2.94, P=0.037) were predictors of subsequent MACE. Conclusion: The present study showed that elevation of circulating levels of sPLA2 was associated with the poor prognosis in patients with AMI undergoing primary PCI.
作者 陈孟英 王伟
出处 《天津医药》 CAS 北大核心 2012年第9期892-894,共3页 Tianjin Medical Journal
关键词 心肌梗死 磷脂酶A2 分泌型 血管成形术 经腔 经皮冠状动脉冠状动脉疾病 预后 myocardial infarction phosPholipases A2, secretory angioplasty, transluminal, percutaneous coronarycoronary artery disease prognosis
  • 相关文献

参考文献1

共引文献3

同被引文献46

  • 1张杰梅,裴汉军,纪晓玲.急性冠脉综合征患者血浆P-选择素及血清一氧化氮水平相关性研究[J].中国分子心脏病学杂志,2011,11(2):75-77. 被引量:5
  • 2孙彦彦,邱春光,韩战营,卢文杰,王卫平,邱承杰,杨长宝,陈晓杰.脂蛋白相关磷脂酶A2与冠状动脉粥样硬化病变程度及斑块稳定性的关系[J].中国实用医刊,2010,37(4):39-41. 被引量:7
  • 3黄仁伦.应激性溃疡发生机制研究进展[J].国际医药卫生导报,2006,12(22):120-122. 被引量:31
  • 4Reibis R, Jannowitz C, Halle M, et al. Management and out- comes of patients with reduced ejection fraction after acute myo- cardial infarction in cardiac rehabilitation centers[J]. Curt Med Res Opin, 2015, 31(2):211-219.
  • 5Chitose T, Sugiyama S, Sakamoto K, et al. Effect of a hydro- philic and a hydrophot)ic statin on cardiac salvage after ST-ele- vated acute myocardial infarction a pilot study[J]. Atherosclero- sis, 2014, 237(1):251-258.
  • 6Kongoi K, Yoneyama K, Koyama K, et ak Early defects iden- tified by computed tomography angiography are associated with left ventricular dysfunction and exercise intolerance following a- cute myocardial infarction[J]. Jpn J Radiol, 2014, 32(10) : 585- 591.
  • 7Montalescot G, Pitt B, Lopez de Sa E, et al. Early eplerenone treatment in patients with acute ST-elevation myocardial infarc- tion without heart failure: the Randomized Double--Blind Re- minder Study[J]. Eur Heart J, 2014, 35 (34): 2295-2302. PMID:24780614.
  • 8O'Malley RG, Bonaca MP, Scirica BM, et al. Prognostic per- formance of multiple biomarkers in patients with non-ST-seg- ment elevation acutecoronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syn- dromes-Thrombolysis In Myocardial Infarction 36)[J]. J Am Coil Cardiol, 2014, 63(16) : 1644-1653.
  • 9Takaya Y, Kumasaka R, Arakawa T, et al. Impact of cardiac rehabilitation on renal function in patients with and without chronic kidney disease after acute myocardial infarction[J]. Cite J, 2014, 78(2):377-384.
  • 10Nursalim A, Suryaatmadja M, Panggabean M. Potential clini- cal application of novel cardiac biomarkers for acute myocardial infarction[J]. Acta Med Indones, 2013, 45(3) 240-250,.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部